ESR1 and breast cancer: The Ca2+-ATPase SPCA2, which is encoded by the ATP2C2 gene, is an epithelial marker that inhibits cell-adhesion protein E-cadherin biogenesis in breast cancer cells regardless of estrogen receptor existence (MCF-7 and MDA-MB-231) [94].